Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Physiomics shares jump on new contract wins

(Sharecast News) - Shares in Physiomics surged on Thursday after the mathematical modelling company was awarded two contracts, one of which was with a new client.

The group, which supports the development of oncology drugs and personalised medicine solutions, has won its first contract with a new unnamed biotech client in the UK. The contract, worth £125,000, relates to a project in the immune-oncology field, is expected to be completed within this calendar year.

Separately, Physiomics also announced it had won a further contract with existing client Merck for an undisclosed amount. The work, which should complete over the next three months, involves "pre-clinical and clinical modelling and simulation of anti-cancer regimens involving combinations of DNA damage/ repair agents", the company said.

Physiomics has now announced four contract awards in August alone.

The stock was up 21% at 1.18p in afternoon trade.

Share this article

Related Sharecast Articles

Cadogan Energy strikes €10m settlement agreement
(Sharecast News) - Exploration and production firm Cadogan Energy said on Friday that it has signed a settlement agreement with Proger Management, Proger Ingegneria, Ma.Lo and TIFS Partecipazioni.
Portmeirion issues profit warning amid 'challenging and unpredictable market conditions'
(Sharecast News) - Pottery business Portmeirion warned on Friday that both revenue and pre-tax profits for the year ending 31 December were now expected to be below market expectations.
Quiz shares slump as group warns of potential need for further funding
(Sharecast News) - Clothing business Quiz warned on Friday that it may require additional funding as decreased footfall weighed on sales in the three months ended 30 November.
Alphawave IP chairman steps down
(Sharecast News) - Semiconductor business Alphawave IP revealed on Thursday that chairman John Holt was set to retire from the group for undisclosed "personal reasons".

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.